• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections.异基因干细胞移植后长期免疫缺陷:B 细胞缺陷与晚期感染相关。
Haematologica. 2010 Jun;95(6):1025-9. doi: 10.3324/haematol.2009.018853. Epub 2010 Feb 4.
2
Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.儿童异基因造血干细胞移植后的体液免疫重建动力学:IgM记忆B细胞的成熟阻滞可能导致抗体免疫重建受损。
Biol Blood Marrow Transplant. 2017 Sep;23(9):1437-1446. doi: 10.1016/j.bbmt.2017.05.005. Epub 2017 May 8.
3
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.异基因造血干细胞移植后的长期免疫缺陷:成年患者的危险因素及并发症
Br J Haematol. 2001 Dec;115(3):630-41. doi: 10.1046/j.1365-2141.2001.03135.x.
4
Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.异基因造血干细胞移植后长期免疫重建和感染负担。
Biol Blood Marrow Transplant. 2014 Apr;20(4):507-17. doi: 10.1016/j.bbmt.2014.01.001. Epub 2014 Jan 7.
5
Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.巨细胞病毒塑造异基因干细胞移植后的长期免疫重建。
Haematologica. 2015 Jan;100(1):114-23. doi: 10.3324/haematol.2014.113415. Epub 2014 Sep 26.
6
Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.低剂量抗胸腺细胞球蛋白对异基因造血细胞移植后免疫重建的影响。
Int J Hematol. 2020 Jan;111(1):120-130. doi: 10.1007/s12185-019-02756-1. Epub 2019 Oct 22.
7
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.原发性免疫缺陷症造血细胞移植后免疫重建和 B 细胞功能的纵向评估。
J Clin Immunol. 2015 May;35(4):373-83. doi: 10.1007/s10875-015-0154-4. Epub 2015 Apr 15.
8
Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.儿童造血细胞移植后的免疫重建:关于影响恢复速度因素的免疫表型分析
Br J Haematol. 2002 Jul;118(1):74-89. doi: 10.1046/j.1365-2141.2002.03560.x.
9
CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.供体移植物中 CD3+/Tregs 比值与异基因外周血造血干细胞移植后的急性移植物抗宿主病和免疫恢复有关。
Biol Blood Marrow Transplant. 2012 Jun;18(6):887-93. doi: 10.1016/j.bbmt.2011.10.039. Epub 2011 Nov 4.
10
B-cell involvement in chronic graft-versus-host disease.B细胞在慢性移植物抗宿主病中的作用。
Haematologica. 2008 Nov;93(11):1702-11. doi: 10.3324/haematol.13311. Epub 2008 Aug 25.

引用本文的文献

1
Immune Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Different Non-T-Cell Depletion Protocols.采用不同非T细胞去除方案的单倍体造血干细胞移植后的免疫重建
MedComm (2020). 2025 May 19;6(6):e70206. doi: 10.1002/mco2.70206. eCollection 2025 Jun.
2
Assessment of Survivorship in Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植中生存情况的评估
Methods Mol Biol. 2025;2907:91-125. doi: 10.1007/978-1-0716-4430-0_5.
3
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analyses.利用单细胞分析技术破译异基因干细胞移植后人类骨髓的植入情况。
J Clin Invest. 2024 Aug 29;134(20):e180331. doi: 10.1172/JCI180331.
4
CD56-mediated activation of human natural killer cells is triggered by Aspergillus fumigatus galactosaminogalactan.CD56 介导的人自然杀伤细胞的激活是由烟曲霉半乳甘露聚糖触发的。
PLoS Pathog. 2024 Jun 18;20(6):e1012315. doi: 10.1371/journal.ppat.1012315. eCollection 2024 Jun.
5
Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipients.肾移植受者接种三剂 COVID-19 疫苗后的体液免疫反应相关因素。
Front Immunol. 2023 Feb 16;14:1099079. doi: 10.3389/fimmu.2023.1099079. eCollection 2023.
6
Immune Response and Outcome of High-Risk Neuroblastoma Patients Immunized with Anti-Idiotypic Antibody Ganglidiomab: Results from Compassionate-Use Treatments.高危神经母细胞瘤患者接受抗独特型抗体神经节苷脂单抗免疫治疗的免疫反应及结果:同情用药治疗的结果
Cancers (Basel). 2022 Nov 25;14(23):5802. doi: 10.3390/cancers14235802.
7
Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review.使用 NIH 共识标准进行慢性移植物抗宿主病的细胞和可溶性生物标志物研究:系统评价。
Front Immunol. 2022 Oct 25;13:1033263. doi: 10.3389/fimmu.2022.1033263. eCollection 2022.
8
Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment.巴利昔单抗治疗后从类固醇难治性急性移植物抗宿主病中康复的患者的免疫重建
Front Oncol. 2022 Jul 15;12:916442. doi: 10.3389/fonc.2022.916442. eCollection 2022.
9
Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias.接受急性白血病异基因干细胞移植儿童的免疫重建和复发风险评分的多变量分析
Transplant Direct. 2021 Oct 6;7(11):e774. doi: 10.1097/TXD.0000000000001226. eCollection 2021 Nov.
10
Modeling Influencing Factors in B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation in Children.儿童造血干细胞移植后 B 细胞重建的影响因素建模。
Front Immunol. 2021 May 7;12:684147. doi: 10.3389/fimmu.2021.684147. eCollection 2021.

本文引用的文献

1
Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.未成熟/过渡性CD21⁻ B淋巴细胞数量升高以及记忆性CD27⁺ B细胞缺乏可识别出患有活动性慢性移植物抗宿主病的患者。
Biol Blood Marrow Transplant. 2008 Feb;14(2):208-19. doi: 10.1016/j.bbmt.2007.10.009.
2
Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.来自匹配相关供体的异基因造血干细胞移植后晚期感染的危险因素。
Biol Blood Marrow Transplant. 2007 Nov;13(11):1304-12. doi: 10.1016/j.bbmt.2007.07.007. Epub 2007 Sep 7.
3
Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends.造血干细胞移植后增强T细胞重建:最新趋势简要更新
Blood Cells Mol Dis. 2008 Jan-Feb;40(1):44-7. doi: 10.1016/j.bcmd.2007.07.015. Epub 2007 Oct 1.
4
Immune reconstitution following hematopoietic stem-cell transplantation.造血干细胞移植后的免疫重建
Best Pract Res Clin Haematol. 2007 Jun;20(2):329-48. doi: 10.1016/j.beha.2006.09.009.
5
Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.异基因造血干细胞移植后的淋巴细胞重建:一项纳入148例患者的回顾性研究。
Bone Marrow Transplant. 2007 May;39(10):613-22. doi: 10.1038/sj.bmt.1705648. Epub 2007 Mar 26.
6
The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.B 系急性淋巴细胞白血病异基因干细胞移植后,急性和慢性移植物抗宿主病对正常及恶性 B 淋巴细胞前体的影响
Haematologica. 2006 Mar;91(3):340-7.
7
Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.异基因干细胞移植后的免疫重建:干细胞来源及移植物抗宿主病的影响
Haematologica. 2005 Jan;90(1):86-93.
8
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning.非清髓性预处理造血细胞移植后的免疫恢复
Exp Hematol. 2003 Oct;31(10):941-52. doi: 10.1016/s0301-472x(03)00201-7.
9
T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions.接受含阿仑单抗预处理方案的去T细胞、低强度异基因干细胞移植并序贯递增剂量供者淋巴细胞输注的多发性骨髓瘤患者的T细胞和B细胞免疫重建及临床结局
Br J Haematol. 2003 Oct;123(2):309-22. doi: 10.1046/j.1365-2141.2003.04612.x.
10
Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial.免疫球蛋白疗法是否应在异基因干细胞移植中使用?一项随机、双盲、剂量效应、安慰剂对照的多中心试验。
Ann Intern Med. 2003 Jul 1;139(1):8-18. doi: 10.7326/0003-4819-139-1-200307010-00007.

异基因干细胞移植后长期免疫缺陷:B 细胞缺陷与晚期感染相关。

Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections.

机构信息

Service d'Hématologie Greffe, & Inserm U728, Hôpital Saint-Louis, 1 Av Vellefaux, 75010 Paris, France.

出版信息

Haematologica. 2010 Jun;95(6):1025-9. doi: 10.3324/haematol.2009.018853. Epub 2010 Feb 4.

DOI:10.3324/haematol.2009.018853
PMID:20133894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2878804/
Abstract

Immune reconstitution was analyzed in 140 consecutive patients who were 2-year disease-free and who underwent myeloablative allogeneic transplantation. A CD4 and CD8 defect was observed involving naive, terminally differentiated, memory and competent cells and above limits values for activated subsets. Natural killer cells normalize at six months while we observed expansion of CD19(+)/CD5(+) B cells after three months and a persisting defect of memory B cells. Chronic graft-versus-host disease did not influence significantly those parameters for CD8 subsets while the naïve and competent CD4 subsets were strongly affected. But the most profound impact of chronic graft-versus-host disease was on B-cell subsets, especially on the memory B population. The cumulative incidence of late severe infections was low (14% at four years). Using Cox's models, only low B-cell counts at 12 (P=0.02) and 24 (P=0.001) months were associated with the hazard of developing late infection, in particular if patients did not develop chronic graft-versus-host disease.

摘要

在 140 例无病生存 2 年且接受清髓性异基因移植的连续患者中分析了免疫重建。观察到 CD4 和 CD8 缺陷,涉及幼稚、终末分化、记忆和有功能细胞以及激活亚群的限值以上。自然杀伤细胞在六个月时恢复正常,而我们在三个月时观察到 CD19(+) / CD5(+) B 细胞的扩增,并且记忆 B 细胞持续存在缺陷。慢性移植物抗宿主病对 CD8 亚群的这些参数没有显著影响,而幼稚和有功能的 CD4 亚群则受到强烈影响。但慢性移植物抗宿主病对 B 细胞亚群的影响最为深远,尤其是对记忆 B 细胞群体。晚期严重感染的累积发生率较低(4 年时为 14%)。使用 Cox 模型,只有在 12 个月(P=0.02)和 24 个月(P=0.001)时的低 B 细胞计数与发生晚期感染的风险相关,特别是如果患者未发生慢性移植物抗宿主病。